To manage blood pressure, 90% of physicians surveyed (162/197 endocrinologists and 196/203 PCPs) currently prescribe ACE inhibitors/ARBs in type 2 diabetes mellitus patients at low risk for diabetic kidney disease. This evidence concerns the gene ACE and diabetic kidney disease.